HBV Antibody
Brelovitug (BJT-778) is a humanized IgG1 neutralizing monoclonal antibody that targets hepatitis B surface antigen (HBsAg) . It exhibits significant antiviral activity by neutralizing and clearing HBV and HDV, as well as eliminating subviral particles containing HBsAg. Brelovitug is applicable for research on HDV and HBV infections, chronic hepatitis D (CHD), and chronic hepatitis B (CHB) .
Product Specifications
Target
HBV
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
249567-ML490 100 µL
NXF2 (Nuclear RNA export Factor 2, FLJ20416, TAPL-2) (MaxLight 490)
Sign In for Pricing
View Details 
GTR15385883 1 Vial
Lentiviral human ALB sgRNA gene knockout kit - Lentiviral human ALB sgRNA gene knockout kit (plasmid)
Sign In for Pricing
View Details 034867-APC 200 µL
DUX4, ID (DUX4, DUX10, Double homeobox protein 4, Double homeobox protein 10, Double homeobox protein 4/10) (APC) discontinued
Sign In for Pricing
View Details MBS256453-01 5 µmol
Adenosine- 5'- O- (1- thiodiphosphate), Rp- isomer (Rp-ADP-alpha-S)
Sign In for Pricing
View Details